The upregulation of miR-195–5p inhibits cell cycle arrest through the downregulation of ADP-ribosylation factor-like protein 2 (ARL2), and low expression of miR-195–5p in MF skin lesions may promote disease progression (40). The gene discussed is ARL2; the disease is mycosis fungoides.